What is the share price of Saamya Biotech (India) Ltd (532905)?

Company share prices are keep on changing according to the market conditions. The current trading price of Saamya Biotech (India) Ltd (532905) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Saamya Biotech (India)?

The latest standalone P/E ratio of Saamya Biotech (India) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Saamya Biotech (India) Ltd (532905)?

The latest standalone P/B ratio of Saamya Biotech (India) Ltd (532905) as of 01-Jan-1970 is 0.17.

What is the 52-week high and low of Saamya Biotech (India) Ltd (532905)?

The 52-week high of Saamya Biotech (India) Ltd (532905) is Rs. 2.07 and the 52-week low is Rs. 1.97.

Saamya Biotech (India) Ltd (532905) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Saamya Biotech (India) Ltd (532905)
Brand: Saamya Biotech (India)

Saamya Biotech (India) Ltd (532905)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532905 NSE: Pharmaceuticals & Drugs | Small Cap | Saamya Biotech (I) Share Price

Saamya Biotech (India) Ltd (532905)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532905 NSE: Pharmaceuticals & Drugs | Small Cap | Saamya Biotech (I) Share Price

Key Metrics

Valuation Multiples

Market Cap

₹5 Cr.

Current Price

₹0

52-Week Low / High

₹2 / 2

TTM EPS

₹-0

TTM Sales

₹0 Cr.

Book Value per Share

₹11.3

P/E Ratio

0.00

Industry PE

46.6

Price to Book (P/B)

0.17

Price to Sales (P/S)

0.00

EV/EBITDA

-406.24

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-1.55%

Return on Capital Employed (ROCE)

-2.93%

Return on Assets (ROA)

-0.58%

Operating Profit Margin

-0.9%

Net Profit Margin

-3.06%

Gross Profit Margin

-0.1%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-49.95%

Operating Profit Growth (1 Year)

-154.17%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

25.62%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹3 Cr.

Equity

₹24.9 Cr.

Face Value

₹10

All Time Low / High

₹0.98 / 31.95

Saamya Biotech (India) stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	TTM
ROCE % ⓘ	0%	0%	0%	0.1%	0.7%	3.5%	-1.1%	0.5%	-2.2%	-2.9%	-
Growth Parameters ⓘ
Sales ⓘ	0	0	0	2.4	16.3	23.1	3	13.4	28.8	14.4	0
Sales YoY Gr.	-	NA	NA	NA	592.8%	41.7%	-87.1%	348.3%	115.3%	-50%	-
Adj EPS ⓘ	0	0	0	0	0.1	-0.1	-0.2	0.1	-0.3	-0.2	-0
YoY Gr.	-	NA	NA	NA	700%	-187.5%	NA	NA	-660%	NA	-
BVPS (₹) ⓘ	10	10	10	10	10.1	11.9	11.8	11.8	11.5	11.4	11.3
Adj Net Profit ⓘ	0	0	0	0	0.2	-0.2	-0.4	0.1	-0.7	-0.5	-0
Cash Flow from Ops. ⓘ	-1	-2.2	-3.9	0.4	-0.7	-1	-0.2	-0.2	0.6	0.1	-
Debt/CF from Ops. ⓘ	-0.6	-0.5	-0	0.4	-0.3	-0.4	-1.8	-20	5.8	39.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-2.4%	69.1%	-50%
Adj EPS ⓘ	NA	-221.3%	NA	NA
BVPSⓘ	1.5%	2.5%	-1.2%	-1.6%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'07	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	TTM
Return on Equity % ⓘ	0	0.1	0.6	-0.5	-1.1	0.4	-2.4	-1.8	-0.1
Op. Profit Mgn % ⓘ	0	1.4	2.6	2.5	-9.1	2.5	0.8	-0.9	NAN
Net Profit Mgn % ⓘ	0	0.9	1.1	-0.8	-12.6	1	-2.4	-3.6	-INF
Debt to Equity ⓘ	0.1	0	0	0	0	0.2	0.1	0.1	-
Working Cap Days ⓘ	0	2,159	145	233	2,599	480	353	1,146	0
Cash Conv. Cycle ⓘ	0	1	3	13	322	42	32	99	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Sales	0	0	0	2.35	16.28	23.07	2.98	13.36	28.77	14.40
Operating Expenses ⓘ +	0	0	0	2.31	15.98	22.49	3.29	13.08	28.53	14.53
Manufacturing Costs	0	0	0	0	0.03	0.03	0.02	0.02	0	0
Material Costs	0	0	0	2.20	15.47	21.32	2.81	12.73	28.38	14.37
Employee Cost	0	0	0	0.01	0.08	0.14	0.06	0.04	0.04	0.04
Other Costs ⓘ	0	0	0	0.10	0.40	1	0.41	0.29	0.11	0.13
Operating Profit ⓘ	0	0	0	0.03	0.30	0.58	-0.31	0.28	0.24	-0.13
Operating Profit Margin (%)	-	-	-	1.3%	1.9%	2.5%	-10.3%	2.1%	0.8%	-0.9%
Other Income ⓘ +	0	0	0	0	0	0.66	0	0	0.03	0.11
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0.04	0.81	0.03	0.02	0	0
Depreciation ⓘ	0	0	0	0	0.07	0.07	0.07	0.12	1	0.92
Profit Before Tax ⓘ	0	0	0	0.03	0.19	0.35	-0.41	0.15	-0.73	-0.94
Tax ⓘ	0	0	0	0.01	0.10	0.08	-0.01	0.06	-0.05	-0.50
Profit After Tax	0	0	0	0.02	0.09	0.28	-0.40	0.10	-0.68	-0.44
PAT Margin (%)	-	-	-	0.9%	0.5%	1.2%	-13.4%	0.7%	-2.4%	-3.1%
Adjusted EPS (₹)	0.0	0.0	0.0	0.0	0.0	0.1	-0.2	0.0	-0.3	-0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Saamya Biotech (I) - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Equity and Liabilities
Shareholders Fund +	8.08	23.09	23.09	23.11	23.20	29.68	29.28	29.38	28.70	28.26
Share Capital ⓘ	8.08	23.09	23.09	23.09	23.09	24.88	24.88	24.88	24.88	24.88
Reserves ⓘ	0	0	0	0.02	0.11	4.80	4.40	4.49	3.81	3.37
Debt +	0.57	1	0.11	0.16	0.22	0.38	0.35	4.43	3.63	3.24
Long Term Debt	0.57	1	0.11	0.16	0.22	0.38	0.35	4.43	3.63	3.24
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0.01	0.04	2.26	7.25	15.98	18.54	10.03	39.83	46.80
Others Liabilities ⓘ	0.94	1.78	1.54	7.80	9.16	4.65	4.96	0.74	0.75	0.51
Total Liabilities ⓘ	9.59	25.88	24.78	33.33	39.83	50.69	53.13	44.57	72.91	78.81
Fixed Assets
Net Fixed Assets ⓘ +	0.35	0.61	0.70	1.64	1.36	1.52	1.38	11.80	10.66	9.54
Gross Block	0.35	0.61	0.70	1.64	1.41	1.64	1.56	12.09	11.85	11.65
Accumulated Depreciation	0	0	0	0	0.05	0.12	0.18	0.29	1.19	2.11
CWIP ⓘ	0	0	0	27.81	28.75	29.02	29.34	18.25	18.25	18.25
Investments ⓘ	0	8.23	0.01	0.01	0	0	0	0	0	0
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0	0	0	2.35	8.18	18.36	21.01	13.16	43.17	50.18
Cash Equivalents	0.01	0.18	0.05	0.07	0.04	0.04	0.01	0.02	0.02	0.02
Others Assets ⓘ	9.23	16.86	24.02	1.45	1.51	1.75	1.39	1.34	0.82	0.82
Total Assets ⓘ	9.59	25.88	24.78	33.33	39.83	50.69	53.13	44.57	72.91	78.81

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Cash Flow From Operating Activity ⓘ +	-1.03	-2.22	-3.85	0.39	-0.74	-1.01	-0.19	-0.22	0.62	0.08
PBT ⓘ	0	0	0	0.03	0.19	0.35	-0.41	0.15	-0.73	-0.94
Adjustment ⓘ	0	0	0	0	0.24	0.10	0.13	0.19	0.97	0.81
Changes in Working Capital ⓘ	-1.03	-2.22	-3.85	0.35	-1.17	-1.46	0.09	-0.56	0.38	0.21
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-0.44	-13.65	4.70	-6.18	-0.85	-0.51	-0.29	0.51	0.17	0.31
Capex	-0.34	-0.27	-0.09	-0.94	0.08	-0.24	0.03	-10.58	0.17	0.31
Net Investments	0	-8.23	8.22	-0	0.01	0	0	0	0	0
Others ⓘ	-0.10	-5.15	-3.44	-5.24	-0.94	-0.27	-0.32	11.09	0	0
Cash Flow From Financing Activity ⓘ +	1.47	16.04	-0.98	5.81	1.56	1.52	0.45	-0.28	-0.80	-0.39
Net Proceeds from Shares ⓘ	0.91	15.61	-0.09	5.77	1.53	3.18	0.48	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0.15	-0.03	-0.30	-0.80	-0.39
Interest Paid ⓘ	0	0	0	0	-0.04	-0.02	-0.02	-0.02	-0	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.57	0.43	-0.89	0.04	0.07	-1.79	0.02	0.04	0	0
Net Cash Flow ⓘ	0	0.17	-0.13	0.02	-0.04	0.01	-0.03	0.01	-0	0

Financial Ratio

PARTICULARS	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16
Ratios
ROE (%)	0	0	0	0.09	0.38	1.05	-1.36	0.33	-2.34	-1.55
ROCE (%)	0	0	0	0.11	0.74	3.54	-1.11	0.5	-2.22	-2.93
Asset Turnover Ratio	0	0	0	0.08	0.46	0.51	0.06	0.29	0.51	0.2
PAT to CFO Conversion(x)	N/A	N/A	N/A	19.5	-8.22	-3.61	N/A	-2.2	N/A	N/A
Working Capital Days
Receivable Days	0	0	0	365	113.40	207.90	2,409	444.60	340.40	1,126.60
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	189.90	112.20	198.80	2,246.30	409.90	320.70	1,100.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Saamya Biotech (India) Ltd FAQs

The current trading price of Saamya Biotech (I) on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Saamya Biotech (I) stood at ₹4.90 Cr

The latest P/E ratio of Saamya Biotech (I) as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Saamya Biotech (I) as of 31-Dec-1969 is 0.17.

The 52-week high of Saamya Biotech (I) is ₹2.07 and the 52-week low is ₹1.97.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Saamya Biotech (I) is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

About Saamya Biotech (India) Ltd

Saamya Biotech (India) was incorporated as a public limited company on August 13, 2002 and certificate of commencement of business was issued on August 26, 2002. The promoters of the company are Dr. Y. Manivardhan Reddy and Dr. Y. Sonia Reddy and it is engaged in business of manufacturing, import, export and dealing in all types of chemicals pharmaceuticals drugs and intermediates.

Saamya Biotech (India) (SBIL) is a new generation biotechnology company incorporated in India (Hyderabad) with the aim to manufacture and market biopharmaceuticals and recombinant protein products of medical and industrial importance, and also to discover and develop emerging biotech products of far reaching significance. The company proposes to set up world class facilities for the manufacture of fermentation based high value biotech products. The company embarks on developing effective strategies for the production and supply of both bulk and formulations with special focus on life saving drug entities at affordable price.

The company has entered into technology transfer agreement with Biofin laboratories s.r.l Italy for technology know-how to manufacture bio-pharmaceutical ingredients.

The company entered into sales and purchase agreement with Finchimica, Italy on September 18, 2004, in terms of which Finchimica, Italy would buy all the products manufactured by it to the extent of 100%.

Product range off the company includes:

Daunomycin
Hyaluronic acid (Pharma grade)
Tacrolimus and Rapamycin
Cyclosporin A, Probiotics
Lysergic acid
Mycophenolic acid
Clavulenic acid
Vancomycin
Co-enzyme Q10
Interferon Î²
Monoclonal antibodies (anti-cancer).

Saamya Biotech (India) Ltd (532905)

Saamya Biotech (India) Ltd (532905)

Saamya Biotech (India) stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Saamya Biotech (I) - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Saamya Biotech (India) Ltd FAQs

About Saamya Biotech (India) Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Saamya Biotech (India) Ltd (532905)

Saamya Biotech (India) Ltd (532905)

Saamya Biotech (India) stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Saamya Biotech (I) - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Saamya Biotech (India) Ltd FAQs

What is the share price of Saamya Biotech (I)?

What is the market cap of Saamya Biotech (I)?

What is the P/E ratio of Saamya Biotech (I)?

What is the P/B ratio of Saamya Biotech (I)?

What is the 52-week high and low of Saamya Biotech (I)?

What is the TTM revenue of Saamya Biotech (I)?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Saamya Biotech (India) Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.